125 related articles for article (PubMed ID: 33476867)
1. Discovery of novel indole derivatives that inhibit NEDDylation and MAPK pathways against gastric cancer MGC803 cells.
Fu DJ; Cui XX; Zhu T; Zhang YB; Hu YY; Zhang LR; Wang SH; Zhang SY
Bioorg Chem; 2021 Feb; 107():104634. PubMed ID: 33476867
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells.
Song J; Cui XX; Wu BW; Li D; Wang SH; Shi L; Zhu T; Zhang YB; Zhang SY
Bioorg Med Chem Lett; 2020 Jan; 30(2):126791. PubMed ID: 31740251
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo.
Fu DJ; Song J; Zhu T; Pang XJ; Wang SH; Zhang YB; Wu BW; Wang JW; Zi X; Zhang SY; Liu HM
Eur J Med Chem; 2020 Apr; 192():112153. PubMed ID: 32135407
[TBL] [Abstract][Full Text] [Related]
5. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers.
Song J; Liu Y; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Fu XJ; Zhang SY
Eur J Med Chem; 2021 Dec; 225():113801. PubMed ID: 34455358
[TBL] [Abstract][Full Text] [Related]
7. Gramine-based structure optimization to enhance anti-gastric cancer activity.
Zhang XH; Guo Q; Wang HY; Li YH; Khamis MY; Ma LY; Wang B; Liu HM
Bioorg Chem; 2021 Feb; 107():104549. PubMed ID: 33383324
[TBL] [Abstract][Full Text] [Related]
8. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma.
Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M
Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells.
He ZX; Huo JL; Gong YP; An Q; Zhang X; Qiao H; Yang FF; Zhang XH; Jiao LM; Liu HM; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 210():112970. PubMed ID: 33153765
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of SL4 against breast cancer cells: induction of G
Wang LH; Jiang XR; Chen GL; Guo W; Zhang JY; Cui LJ; Li HH; Li M; Liu X; Yang JY; Wu CF
Sci Rep; 2016 Nov; 6():36486. PubMed ID: 27819344
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives.
Xu XL; Yu CL; Chen W; Li YC; Yang LJ; Li Y; Zhang HB; Yang XD
Org Biomol Chem; 2015 Feb; 13(5):1550-7. PubMed ID: 25491254
[TBL] [Abstract][Full Text] [Related]
12. Facile one-pot synthesis, antiproliferative evaluation and structure-activity relationships of 3-amino-1H-indoles and 3-amino-1H-7-azaindoles.
Diao PC; Hu MJ; Yang HK; You WW; Zhao PL
Bioorg Chem; 2019 Jul; 88():102914. PubMed ID: 30991193
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Novel Cytotoxic Indole-Thiosemicarbazone Derivatives: Biological Evaluation and Docking Study.
Bakherad Z; Safavi M; Fassihi A; Sadeghi-Aliabadi H; Bakherad M; Rastegar H; Saeedi M; Ghasemi JB; Saghaie L; Mahdavi M
Chem Biodivers; 2019 Apr; 16(4):e1800470. PubMed ID: 30845369
[TBL] [Abstract][Full Text] [Related]
16. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization.
Yan J; Hu J; An B; Huang L; Li X
Eur J Med Chem; 2017 Jan; 125():663-675. PubMed ID: 27721152
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
[TBL] [Abstract][Full Text] [Related]
19. Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors.
Fu DJ; Li P; Wu BW; Cui XX; Zhao CB; Zhang SY
Eur J Med Chem; 2019 Mar; 165():309-322. PubMed ID: 30690300
[TBL] [Abstract][Full Text] [Related]
20. Marine-Inspired Bis-indoles Possessing Antiproliferative Activity against Breast Cancer; Design, Synthesis, and Biological Evaluation.
Eldehna WM; Hassan GS; Al-Rashood ST; Alkahtani HM; A Almehizia A; Al-Ansary GH
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32252280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
